This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Eva Marie Prinz: Innovator in Pharmaceutical Formulations
Introduction
Eva Marie Prinz is a notable inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. Her work focuses on improving treatment options for neonatal brain injury.
Latest Patents
Eva Marie Prinz holds a patent for "Melatonin-based formulations for parenteral administration." This patent involves pharmaceutical formulations comprising nanoparticles of melatonin, which are useful for the treatment of neonatal brain injury. She has 1 patent to her name, showcasing her commitment to advancing medical science.
Career Highlights
Eva is currently employed at Chiesi Farmaceutici S.p.a., a company known for its dedication to research and development in the pharmaceutical sector. Her role at Chiesi allows her to apply her innovative ideas in a practical setting, contributing to the company's mission of improving patient care.
Collaborations
Throughout her career, Eva has collaborated with talented professionals, including Annamaria Soliani Raschini and Akif Emre Türeli. These collaborations have enriched her research and expanded the impact of her work in the pharmaceutical industry.
Conclusion
Eva Marie Prinz is a pioneering inventor whose work in melatonin-based formulations is making a difference in neonatal healthcare. Her contributions to Chiesi Farmaceutici S.p.a. and her collaborations with esteemed colleagues highlight her dedication to innovation in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile